TrialBMC psychiatry2026

Risperidone for children with attention-deficit/hyperactivity disorder and severe behavioral dysregulation: a randomized placebo-controlled assessor-blinded trial.

Ezatollah Abbasi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.